Literature DB >> 17466414

AD brain pathology: vascular origins? Results from the HAAS autopsy study.

Lenore J Launer1, Helen Petrovitch, G Webster Ross, William Markesbery, Lon R White.   

Abstract

An increasing number of studies suggest a vascular contribution to Alzheimer's disease (AD). One major question these findings raise is whether vascular disease enhances the formation of AD-like lesions, or whether vascular disease just adds to clinical severity. We examined this question in a fully characterized autopsy sample based on the Honolulu Asia Aging Study. We found that AD markers of neurodegeneration (amyloid plaques, cerebral amyloid angiopathy and neurofibrillary tangles) were no more prevalent in those with neuropathologically defined vascular lesions compared to those without lesions. Our study suggests the burden of vascular and AD type lesions are independent of each other, and are consistent with an additive effect of the two types of lesions on cognitive impairment.

Entities:  

Mesh:

Year:  2007        PMID: 17466414      PMCID: PMC3437222          DOI: 10.1016/j.neurobiolaging.2007.03.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

Review 1.  Neurovascular regulation in the normal brain and in Alzheimer's disease.

Authors:  Costantino Iadecola
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

Review 2.  Demonstrating the case that AD is a vascular disease: epidemiologic evidence.

Authors:  Lenore J Launer
Journal:  Ageing Res Rev       Date:  2002-02       Impact factor: 10.895

3.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.

Authors:  D A Snowdon; L H Greiner; J A Mortimer; K P Riley; P A Greiner; W R Markesbery
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

4.  AD lesions and infarcts in demented and non-demented Japanese-American men.

Authors:  Helen Petrovitch; G Webster Ross; Sandra C Steinhorn; Robert D Abbott; William Markesbery; Daron Davis; James Nelson; John Hardman; Kamal Masaki; Margaret R Vogt; Lenore Launer; Lon R White
Journal:  Ann Neurol       Date:  2005-01       Impact factor: 10.422

5.  Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.

Authors:  Yanming Wang; William E Klunk; Manik L Debnath; Guo-Feng Huang; Daniel P Holt; Li Shao; Chester A Mathis
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 6.  Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins.

Authors:  Ivan Casserly; Eric Topol
Journal:  Lancet       Date:  2004-04-03       Impact factor: 79.321

7.  Amyloid at the blood vessel wall.

Authors:  John Hardy; Karen Cullen
Journal:  Nat Med       Date:  2006-07       Impact factor: 53.440

  7 in total
  53 in total

Review 1.  Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.

Authors:  Oscar L Lopez; James T Becker; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Cerebrovascular lesions induce transient β-amyloid deposition.

Authors:  Monica Garcia-Alloza; Julia Gregory; Kishore V Kuchibhotla; Sara Fine; Ying Wei; Cenk Ayata; Matthew P Frosch; Steven M Greenberg; Brian J Bacskai
Journal:  Brain       Date:  2011-11-26       Impact factor: 13.501

Review 3.  Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke.

Authors:  Rebecca F Gottesman; Argye E Hillis
Journal:  Lancet Neurol       Date:  2010-09       Impact factor: 44.182

4.  The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy.

Authors:  Akihiko Shiino; Toshiyuki Watanabe; Yoshitomo Shirakashi; Emi Kotani; Masahiro Yoshimura; Shigehiro Morikawa; Toshiro Inubushi; Ichiro Akiguchi
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-08       Impact factor: 6.200

Review 5.  Vascular basis for brain degeneration: faltering controls and risk factors for dementia.

Authors:  Raj N Kalaria
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

6.  Modeling regional vulnerability to Alzheimer pathology.

Authors:  Donald R Royall; Raymond F Palmer; Helen Petrovitch; G Webster Ross; Kamal Masaki; Lon R White
Journal:  Neurobiol Aging       Date:  2011-07-30       Impact factor: 4.673

7.  Diffusion tensor imaging of the hippocampus and verbal memory performance: the RUN DMC study.

Authors:  Anouk G W van Norden; Karlijn F de Laat; Ilma Fick; Inge W M van Uden; Lucas J B van Oudheusden; Rob A R Gons; David G Norris; Marcel P Zwiers; Roy P C Kessels; Frank-Erik de Leeuw
Journal:  Hum Brain Mapp       Date:  2011-03-09       Impact factor: 5.038

Review 8.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

9.  Residual decline in cognition after adjustment for common neuropathologic conditions.

Authors:  Lei Yu; Patricia A Boyle; Eisuke Segawa; Sue Leurgans; Julie A Schneider; Robert S Wilson; David A Bennett
Journal:  Neuropsychology       Date:  2014-12-15       Impact factor: 3.295

10.  Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia.

Authors:  Lei Yu; Vladislav A Petyuk; Chris Gaiteri; Sara Mostafavi; Tracy Young-Pearse; Raj C Shah; Aron S Buchman; Julie A Schneider; Paul D Piehowski; Ryan L Sontag; Thomas L Fillmore; Tujin Shi; Richard D Smith; Philip L De Jager; David A Bennett
Journal:  Ann Neurol       Date:  2018-07-03       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.